Advertisement

Topics

"A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease" Drugs and Medication Database

15:29 EST 16th February 2019 | BioPortfolio

Here are the most relevant "A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease" Drugs and Medications that we have found in our database.

More Information about "A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease" on BioPortfolio

We have published hundreds of A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease news stories on BioPortfolio along with dozens of A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease Clinical Trials and PubMed Articles about A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease Companies in our database. You can also find out about relevant A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease Drugs and Medications on this site too.

Showing "Meta analysis Drug Eluting Stents Versus Bare Metal" Drugs and Medications 1–25 of 60

Possibly Relevant

Brilinta [cardinal health]

These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA. BRILINTA® (ticagrelor) tablets, for oral useInitial U.S. Approval: 2011

Brilinta [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA. BRILINTA® (ticagrelor) tablets, for oral useInitial U.S. Approval: 2011

Ticagrelor [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use TICAGRELOR TABLETS safely and effectively. See full prescribing information for TICAGRELOR TABLETS.   TICAGRELOR tablets, for oral use Initial U.S. Approval: 2011

Glucoheptonate [anazaohealth corporation]

Glucoheptonate

Cyclo/mag [living well pharmacy, inc.]

CYCLO/MAG KIT

Cyclo/mag 10mg/200mg [living well pharmacy, inc.]

CYCLO/MAG KIT

Bal [akorn, inc.]

BAL in Oil AmpulesDIMERCAPROL INJECTION, USP

Bivalirudin [auromedics pharma llc]

These highlights do not include all the information needed to use BIVALIRUDIN FOR INJECTION safely and effectively. See full prescribing information for BIVALIRUDIN FOR INJECTION. BIVALIRUDIN for injection, for intravenous use Initial U.S. Approval: 2000

Collagenase santyl [smith & nephew, inc]

COLLAGENASE SANTYL ointment 250 units/g [SMITH & NEPHEW, INC]

Erythromycin [renaissance pharma, inc.]

Erythromycin Topical Gel

Erygel [prestium pharma, inc.]

ERYGEL

Erythromycin [teligent pharma, inc.]

Erythromycin Topical Gel USP, 2%

Bleomycin [hospira, inc.]

Bleomycin for Injection, USP

Erythromycin [perrigo new york inc]

Erythromycin Topical Gel USP, 2%

Reopro [eli lilly and company]

ReoPro Abciximab

Reopro [janssen biotech, inc.]

ReoPro Abciximab

Prasugrel [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral use Initial U.S. Approval: 2009

Prasugrel [mylan pharmaceuticals inc.]

These highlights do not include all the information needed to use PRASUGREL TABLETS safely and effectively. See full prescribing information for PRASUGREL TABLETS. PRASUGREL tablets, for oral useInitial U.S. Approval: 2009

Methylene blue [general injectables & vaccines, inc]

Methylene Blue 10 mg/mL Injection, USP 10 mL Single Dose Vial

Methylene blue [akorn, inc.]

Methylene Blue Injection 1%

Arikayce [insmed incorporated]

These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S. Approval: 2018 LIMIT

Onglyza [cardinal health]

These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets, for oral useInitial U.S. Approval: 2009

Onglyza [physicians total care, inc.]

These highlights do not include all the information needed to use ONGLYZA safely and effectively. See full prescribing information for ONGLYZA. ONGLYZA (saxagliptin) tablets Initial U.S. Approval: 2009

Baxdela [melinta therapeutics, inc]

These highlights do not include all the information needed to use BAXDELA safely and effectively. See full prescribing information for BAXDELA. BAXDELA (delafloxacin) tablets, for oral use BAXDELA (delafloxacin) for injection, for intravenous use Initial

Ciclopirox [taro pharmaceuticals, inc.]

Ciclopirox Shampoo, 1%



Advertisement
Quick Search
Advertisement
Advertisement